TCL Archive Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research January 28, 1994
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009